Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein

American Journal of Pathology

Volumn 165, Issue 5, 2004, Pages 1643-1652

  Bellucci, Arianna ^a,c   Westwood, Andrew J ^a   Ingram, Esther ^a   Casamenti, Fiorella ^c   Goedert, Michel ^b   Spillantini, Maria Grazia ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; ENZYME; INTERLEUKIN 1BETA; TAU PROTEIN;

ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; ENCEPHALITIS; IMMUNOREACTIVITY; MICROGLIA; MOUSE; NERVE CELL; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; TAUOPATHY; TRANSGENIC MOUSE;

EID: 7244242262     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63421-9     Document Type: Article

References (51)

1. Goedert M, Spillantini MG, Davies SW: Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol 1998, 8:619-632
2. Lee VMY, Goedert M, Trojanowski JQ: Neurodegenerative tauopathies. Annu Rev Neurosci 2001, 24:1121-1159
3. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg GD: Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998, 43:815-825
4. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski JQ, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JBJ, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T, Heutink P: Association of missense and 5′-splice- site-mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705
5. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B: Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998, 95:7737-7741
6. Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, van Slegtenhorst M, Gwinn-Hardy K, Murphy MP, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, Dickson DW, Davies P, Hutton M: Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 2000, 25:402-405
7. Götz J, Chen F, Barmettler R, Nitsch RM: Tau filament formation in transgenic mice expressing P301L tau. J Biol Chem 2001, 276:529-534
8. Lim F, Hernandez F, Lucas JJ,Gomez-Ramos P, Moran MA, Avila J: FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and tau filaments in forebrain. Mol Cell Neurosci 2001, 18:702-714
9. Tanemura K, Murayama M, Akagi T, Hashikawa T, Tominaga T, Ichikawa M, Yamaguchi H, Taskashima A: Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J Neurosci 2002, 22:133-141
10. Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, Yoshida H, Holzer M, Craxton M, Emson PC, Atzori C, Migheli A, Crowther RA, Ghetti B, Spillantini MG, Goedert M: Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 2002, 22:9340-9351
11. Tatebayashi Y, Miyasaka T, Chui DH, Akagi T, Mishima KI, Iwasaki K, Fujiwara M, Tanemura K, Murayama M, Ishiguro K, Planel E, Sato S, Hashikawa T, Takashima A: Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Proc Natl Acad Sci USA 2002, 99:13896-13901
12. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM: Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 2003, 39:409-421
13. Bugiani O, Murrell JR, Giaccone G, Hasegawa M, Ghigo S, Tabaton M, Morbin M, Primavera A, Carella F, Solaro C, Grisoli M, Savoiardo M, Spillantini MG, Tagliavini F, Goedert M, Ghetti B: Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in Tau. J Neuropathol Exp Neurol 1999, 58:667-677
14. Goedert M, Jakes R, Crowther RA: Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett 1999, 450:306-311
15. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WST, Hampel H, Hull M, Landreth G, Lue LF, Mrak R, Mackenzie IR, McGeer PL, O'Banion K, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T: Inflammation and Alzheimer's disease. Neurobiol Aging 2000, 21:383-421
16. McGeer PL, Schulzer M, McGeer EG: Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996, 47:425-432
17. Probst A, Götz J, Wiederhold KH, Tolnay M, Mistl C, Jalon AL, Hong M, Ishihara T, Lee VMY, Trojanowski JQ, Jakes R, Crowther RA, Spillantini MG, Bürki K, Goedert M: Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol 2000, 99:469-481
18. Goedert M, Jakes R, Vanmechelen E: Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995, 189:167-170
19. Hasegawa M, Jakes R, Crowther RA, Lee VMY, Ihara Y, Goedert M: Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein. FEBS Lett 1996, 384:25-30
20. Goedert M, Spillantini MG, Cairns NJ, Crowther RA: Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 1992, 8:159-168
21. Lechan R, Toni R, Clark B, Cannon J, Shaw A, Dinarello C, Reichlin S: Immunoreactive interleukin-1β localization in the rat forebrain. Brain Res 1990, 514:135-140
22. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF: Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993, 11:371-386
23. Li M, Ona VO, Guégan C, Chen M, Jackson-Lewis V, Andrews LJ, Olszewski AJ, Stieg PE, Lee JP, Przedborski S, Friedlander RM: Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 2000, 288:335-339
24. Almer G, Guégan C, Teismann P, Naini A, Rosoklija G, Hays AP, Chen C, Przedborski S: Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 2001, 49:176-185
25. Rockwell P, Yuan H, Magnusson R, Figueiredo-Pereira ME: Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGEs. Arch Biochem Biophys 2000, 374:25-33
26. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL, Araoz C: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989, 86:7611-7615
27. Pasinetti GM, Aisen PS: Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 1998, 87:319-324
28. Oka A, Takashima A: Induction of cyclooxygenase-2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons. Neuroreport 1997, 8:1161-1164
29. Nakayama M, Uchimura K, Zhu RL, Nagayama T, Rose ME, Stetler RA, Isakson PC, Chen J, Graham SH: Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci USA 1998, 95:10954-10959
30. Serou MJ, DeCoster MA, Bazan NG: Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression. J Neurosci Res 1999, 58:593-598
31. Hoozemans JJM, Veerhuis R, Janssen I, Rozemuller AJM, Eikelenboom P: Interleukin-1β induced cyclooxygenase 2 expression and prostaglandin E2 secretion by human neuroblastoma cells: implications for Alzheimer's disease. Exp Gerontol 2001, 36:559-570
32. Andreasson KI, Savonenko A, Vidensky S, Goellner JJ, Zheng Y, Shatter A, Kaufmann WE, Worley PF, Isakson P, Markowska AL: Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J Neurosci 2001, 21:8198-8209
33. Drachman DB, Frank K, Dykes-Hoberg M, Teismann P, Aimer G, Przedborski S, Rothstein JD: Cyclooxygenase-2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol 2002, 52:771-778
34. Pompl PN, Ho L, Bianchi M, McManus T, Qin W, Pasinetti GM: A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic model of amyotrophic lateral sclerosis. FASEB J 2003, 17:725-727
35. Drachman DB, Rothstein JD: Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis. Ann Neurol 2000, 48:792-795
36. McGeer PL, Akiyama H, Itagaki S, McGeer EG: Immune system response in Alzheimer's disease. Can J Neurol Sci 1989, 16:516-527
37. Haga S, Akai K, Ishii T: Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol 1989, 77:569-575
38. Schwab C, Steele JC, McGeer PL: Neurofibrillary tangles of Guam parkinsonism-dementia are associated with reactive microglia and complement proteins. Brain Res 1996, 707:196-205
39. Ishizawa K, Dickson DW: Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J Neuropathol Exp Neurol 2001, 60:647-657
40. McGeer PL, Itagaki S, Boyes BE, McGeer EG: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988, 38:1285-1291
41. Mackenzie IRA: Activated microglia in dementia with Lewy bodies. Neurology 2000, 55:132-134
42. Ishizawa K, Komori T, Sasaki S, Arai N, Mizutani T, Hirose T: Microglial activation parallels system degeneration in multiple system atrophy. J Neuropathol Exp Neurol 2004, 63:43-52
43. Kawatama T, Akiyama H, Yamada T, McGeer PL: Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord. Am J Pathol 1992, 140:691-707
44. Cras P, Kawai M, Siedlak S, Perry G: Microglia are associated with the extracellular neurofibrillary tangles of Alzheimer disease. Brain Res 1991, 558:312-314
45. Ikeda K, Akiyama H, Haga C, Haga S: Evidence that neurofibrillary tangles undergo glial modification. Acta Neuropathol 1992, 85:101-104
46. Gonzalez-Scarano F, Baltuch G: Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 1999, 22:219-240
47. Frade JM, Barde YA: Microglia-derived nerve growth factor causes cell death in the developing retina. Neuron 1998, 20:35-41
48. Marin-Teva J, Dusart I, Colin C, Gervais A, van Rooijen N, Mallat M: Microglia promote the death of developing Purkinje cells. Neuron 2004, 41:535-547
49. Sedel F, Béchade C, Vyas S, Triller A: Macrophage-derived tumor necrosis factor alpha, an early developmental signal for motoneuron death. J Neurosci 2004, 24:2236-2246
50. Reddien PW, Cameron S, Horvitz HR: Phagocytosis promotes programmed cell death in C. elegans. Nature 2001, 412:198-202
51. Hoeppner DJ, Hengartner MO, Schnabel R: Engulfment genes cooperate with ced-3 to promote cell death in Caenorhabditis elegans. Nature 2001, 412:202-206